Search clinical trials for: Placebo matched phentermine/topiramate

Total 598 results

VIVUS LLC
Medpace, Inc.

Completed

Study of VI-0521 Compared to Placebo in Treatment of Obesity in Adults

Obesity

United States
University of California, San Diego

Recruiting

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

Obesity | Colitis, Ulcerative

United States
VIVUS LLC
Synteract, Inc.; Sentrx

Completed

A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults

Diabetes

United States
Stanford University

Completed

FDA Approved Medication to Reduce Binge Eating and/or Purging

Bulimia Nervosa | Binge Eating Disorder

United States
University of Minnesota

Recruiting

Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity

Pediatric Obesity

United States
University of Minnesota

Recruiting

Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity

Obesity

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients

Obesity

United States
Seattle Children's Hospital
Children's Hospital of Philadelphia

Not yet recruiting

Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

Craniopharyngioma | Hypothalamic Obesity | Hypothalamic Tumor

United States
VIVUS LLC

Completed

A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subjects

Blood Pressure

United States
Mayo Clinic

Completed

Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker

Obesity

United States
VIVUS LLC
Covance; Sentrx

Completed

A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment

Hepatic Impairment

United States
VIVUS LLC
Medpace, Inc.

Completed

A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults

Obesity

United States
University of Minnesota
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

SMART Use of Medication for the Treatment of Adolescent Severe Obesity (SMART)

Adolescent Obesity

United States
Denver Health and Hospital Authority

Completed

A Toolbox Approach to Obesity Treatment in Primary Care (Toolbox)

Obesity

United States
VIVUS LLC

Completed

A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents

Pediatric Obesity | Childhood Obesity

United States
VIVUS LLC

Completed

Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects

Obesity

United States
VIVUS LLC

Completed

Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults

Obesity

United States
Wake Forest University Health Sciences
VIVUS LLC

Completed

Qsymia as an Adjunct to Surgical Therapy in the Superobese

Obesity | Weight Loss | Metabolic Surgery | Bariatric Surgery Procedures

United States
VIVUS LLC

Completed

A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity

Adolescent Obesity | Obesity in Adolescence | Adolescent Overweight

United States
Eisai Inc.

Completed

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

Chronic Weight Management

United States
Medical College of Wisconsin

Recruiting

Risk of Metabolic Adaptation After Weight Loss

Obesity | Weight Loss

United States
Gateway Institute for Brain Research

Recruiting

Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease (NOSE-PD)

Parkinson Disease

United States
Jaime Moore, MD MPH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Completed

Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds

Adolescent | Obesity, Morbid | Drug Therapy | Bariatric Surgery | Young Adult

United States
VIVUS LLC

Completed

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Renal Impairment

United States
GlaxoSmithKline

Completed

Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy

Muscular Dystrophies

Germany, Belgium, Turkey, Netherlands, Spain, Israel, Australia, France, United Kingdom
Ore Pharmaceuticals, Inc.

Unknown

Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis

Mild to Moderate Ulcerative Colitis

Canada, India
Montefiore Medical Center
United States Department of Defense; Jazz Pharmaceuticals

Recruiting

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

Autism Spectrum Disorder

United States
Takeda

Terminated

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants

Pharmacokinetics | Pharmacodynamics | Tolerability | Safety

United States
Pfizer

Terminated

A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers

Sleep | Healthy Volunteers

United States
E-Star BioTech, LLC
Mayo Clinic; PPD

Not yet recruiting

To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension

Difficult to Control Hypertension
Eisai Inc.

Completed

A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants

Healthy Volunteers

United States
Eisai Inc.

Completed

A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants

Healthy Volunteers

United States
Eisai Inc.

Completed

A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants

Healthy Volunteers

United States
Pfizer

Completed

Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers

Healthy | Sleep

United States
Eisai Inc.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects

Healthy Subjects

United States
Bristol-Myers Squibb

Completed

To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants

Thrombosis

United States
Moleac Pte Ltd.

Completed

Study of NeuroAid In Enhancing Recovery After Stroke (TIERS)

Stroke | Cerebral Infarction

Singapore
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Epilepsy | Seizures | Partial Seizure Disorder

United States, Australia, France, Belgium, Taiwan, Spain, Argentina, Poland, India, Ukraine, Finland, Korea, Republic of, Russian Federation, Chile, Thailand, Hungary, Israel, New Zealand, Canada, Mexico, Norway, Netherlands, South...
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children

Migraine | Vascular Headaches
University of Florida
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Obesity and Uric Acid Stones Study

Obesity | Type 2 Diabetes Mellitus in Obese | Pre-Diabetes | Uric Acid Stones

United States
University of Copenhagen
R W Johnson Pharmaceutical Research Institute

Terminated

Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese Subjects (TOBES)

Obesity

Denmark
Virginia Commonwealth University
National Institute of Neurological Disorders and Stroke (NINDS); NeuroNEXT...

Completed

Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN) (TopCSPN)

Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome

United States
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Center...

Completed

Topiramate Treatment of Problem Drinkers

Alcohol Drinking

United States
Janssen Pharmaceutica N.V., Belgium

Completed

The Prolonged Use of Topiramate for Preventing Migraine Headaches (PROMPT)

Migraine

France, Poland, United Kingdom, Belgium, Germany, Spain, Portugal, Slovenia, Bulgaria, Saudi Arabia, Switzerland, Denmark, Greece, Russian Federation, Turkey, Hungary, Austria, Ireland, Norway, Czech Republic
Ipsen

Recruiting

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis (ELFIDENCE)

Primary Biliary Cholangitis (PBC)

United States, Spain, Romania
EMD Serono
Merck KGaA, Darmstadt, Germany

Terminated

Atacicept in Subjects With Optic Neuritis

Optic Neuritis

United States, France, Spain, United Kingdom, Canada, Germany, Czech Republic, Belgium, Australia, Switzerland, Lebanon
Florida State University

Completed

Nighttime Feeding and Morning Endurance Performance

Poor Performance Status

United States
Navitor Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc.

Recruiting

Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression

Treatment Resistant Depression

United States
Destiny Pharma Plc

Completed

Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection

Staphylococcal Infections | Surgical Site Infection

United States, Serbia, Georgia
National University Hospital, Singapore

Completed

NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects (NEURITES)

Cognitive Impairment

Singapore, Philippines, Vietnam

Search clinical trials for: Placebo matched phentermine/topiramate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations